Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04033328
Title Study of ORIC-101 in Combination With Enzalutamide
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors Oric Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field